Pfizer-BioNTech was said to have won a contract with the Philippines for the supply of the COVID-19 vaccine. It was reported that the country just signed a deal with the American multinational pharmaceutical and biotechnology company for 40 million doses of the vaccines.
The Philippines and Pfizer deal for coronavirus shots
As per Reuters, this is so far the biggest order of Pfizer COVID-19 vaccine from the Philippines. Secretary Carlito Galvez, the National Task Force chief against coronavirus, announced the deal with Pfizer on Sunday, June 20, and revealed that deliveries could be expected to begin in August.
In addition to this new order from Pfizer-BioNTech, the Philippines has now secured the delivery of 113 million doses of vaccine from five suppliers that include China's Sinovac (26 million doses), Moderna (20 million), Russia's Sputnik V (10 million) and AstraZeneca (17 million).
The vaccine supply in Manila is still limited and in some provinces, the government recorded a surge in COVID-19 cases, which complicates efforts to work up on the immunization drive. But with the upcoming Pfizer supply, officials are hoping that it will reach more people and eventually lessen the cases.
“We are very happy to report that the government and the management of Pfizer have finally concluded our negotiations, Philippine News Agency quoted Galvez as saying. “Health Secretary Francisco Duque and I signed yesterday (Saturday, June 19) the supply agreement for the biggest and most decisive deal we had for 2021.”
More vaccine jabs for the Filipinos
Galvez added that 20 million Filipinos will benefit from this Pfizer COVID-19 supply deal. The Philippines is not just waiting for deliveries from the American biotech company, but it is also expecting deliveries from the COVAX facility. In addition, a total of 16 million doses are coming from Jonhson & Johnson and Novavax as well.
Meanwhile, the Philippines will be allowing the administration of the Pfizer-BioNTech vaccines to youngsters ages 12 to 15. Their inoculation may begin later this year once the vaccine inventory expands and the priority group’s vaccinations are completed.


Bumble Shares Surge 50% on $1 Billion Buyout Talks
Oil Prices Fall as Russia Signals Higher Diesel Exports
Samsung, SK Hynix Shares Plunge as China Chip Competition Grows
Citi Upgrades Galaxy Digital Stock, Raises Price Target to $28
Oil Prices Surge Above $106 After Deadly Saudi Airport Attack
Tesla Holds $960 Million in Bitcoin as BTC Gains Top $710 Million
IMF Maintains 2027 Global Growth Forecast at 3.4% Amid Rising Risks
RBA Signals More Rate Hikes as Inflation Risks Rise
Arm Shares Fall Over 3% After Qualcomm Wins License Dispute
Most Americans Oppose Election Betting on Prediction Markets, Poll Finds
Fed's Hammack Urges Faster Rate Hikes to Fight Inflation
Oil Prices Fall as Trump Ceasefire Claim Shifts Market Focus to U.S. CPI
Moonshot AI Executives Seek Settlement Ahead of Hong Kong IPO
Wall Street Closes Lower as Bank Earnings and AI Concerns Weigh
Nvidia Invests in Four French AI Companies to Expand European Presence
Visa Wins China Approval to Prepare Domestic Payments Expansion
MNX Crypto Exchange Launches Futures for OpenAI, Anthropic Valuations 



